Biology of Blood and Marrow Transplantation · 2019 · 19 citations · 16 references
MedicineHematologyImmunologyStem Cell TransplantationTransfusion MedicineTransplant ImmunologyHematopoietic Stem Cell Transplant PharmacotherapyTransfusion SupportTransplant Infectious ComplicationsTransplant OutcomesTransplant SurvivalAplastic Anemia TransplantationFludarabine-based RegimensHematopoietic Stem Cell Transplant ConditioningMatched Unrelated Donor TransplantationMismatched Donor TransplantationRelated Donor MatchingRelated Donor TransplantationTransplantation Outcome Assessment
/kg. Median days for neutrophil engraftment was 13 (range, 10 to 20) and platelet engraftment 20 (range, 14 to 43). Day 100 mortality was 7.5% (n = 11). Sustained successful engraftment was achieved in 87.8% of patients (n = 129). Most graft failures (40%) occurred in Flu2 conditioning (P = .000) and in patients with >2 risk factors (P = .000). Overall incidence of acute and chronic GVHD was 11.6% (n = 17) and 12.9% (n = 19), respectively, in Flu1 and Flu2 groups. Overall survival (OS), disease-free survival (DFS), and GVHD-free relapse-free survival (GRFS) was 83.7%, 78.2%, and 70.7%, respectively. A trend toward improved OS was observed in patients receiving Flu1 conditioning but was statistically nonsignificant (P = .256), whereas DFS and GRFS were significantly better in Flu1 versus Flu2 (P = .004 and .001, respectively). When stratified per number of risk factors (age > 20, RBC concentrate > 20 or platelet > 50 random, duration > 3 months, previous HSCT), OS and DFS decreased significantly with increasing number of risk factors (P = .000 and .001, respectively). Patients are able to tolerate Flu-based conditioning well with lower rates of rejection and excellent long-term survival in high-risk AA patients. Cyclosporine alone as GVHD prophylaxis and marrow source stem cells as graft source are preferable options. Use of Flu plus low-dose Cy conditioning is associated with inferior survival outcomes. A randomized trial of Flu-based versus conventional Cy-containing conditioning would be helpful in establishing a standard of care conditioning regimen in high-risk AA patients.
16
Guidelines for the diagnosis and management of adult aplastic anaemia
Sally Killick, Nick Bown, Jamie Cavenagh et al. · British Journal of Haematology · 2015 · 752 citations
Anna Locasciulli, Rosi Oneto, Almalina Bacigalupo et al. · Haematologica · 2007 · 324 citations · Full text
Medicine, Hematology, Pediatrics +16
Selection of patients for bone marrow transplantation in severe aplastic anemia
BM Camitta, JM Rappeport, Robertson Parkman et al. · Blood · 1975 · 306 citations · Full text
Long-term outcome after bone marrow transplantation for severe aplastic anemia
Lionel Adès, Jean‐Yves Mary, Marie Robin et al. · Blood · 2003 · 211 citations · Full text